406
Views
137
CrossRef citations to date
0
Altmetric
Review

Inhaled chemotherapy in lung cancer: future concept of nanomedicine

, , , , , , & show all
Pages 1551-1572 | Published online: 22 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (17)

Pooneh Kia, Umme Ruman, Ariyati Retno Pratiwi & Mohd Zobir Hussein. (2023) Innovative Therapeutic Approaches Based on Nanotechnology for the Treatment and Management of Tuberculosis. International Journal of Nanomedicine 18, pages 1159-1191.
Read now
Yishuai Liu, Zixuan Zhao, Shuhui Zhu, Yumin Cheng, Jun Liu, Tiantian Ye & Shujun Wang. (2023) Docetaxel liposomes for lung targeted delivery: development and evaluation. Pharmaceutical Development and Technology 28:9, pages 856-864.
Read now
Kholoud E Albinali, Moustafa M Zagho, Yonghui Deng & Ahmed A Elzatahry. (2019) A perspective on magnetic core–shell carriers for responsive and targeted drug delivery systems. International Journal of Nanomedicine 14, pages 1707-1723.
Read now
Yukimune Kanehira, Kohei Togami, Kiyomi Ishizawa, Shingo Sato, Hitoshi Tada & Sumio Chono. (2019) Intratumoral delivery and therapeutic efficacy of nanoparticle-encapsulated anti-tumor siRNA following intrapulmonary administration for potential treatment of lung cancer. Pharmaceutical Development and Technology 24:9, pages 1095-1103.
Read now
Xiaofei Wang, Qinyue Chen, Xiaoyan Zhang, Xiaoqing Ren, Xiulei Zhang, Lin Meng, Huihui Liang, Xianyi Sha & Xiaoling Fang. (2018) Matrix metalloproteinase 2/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro/in vivo studies. International Journal of Nanomedicine 13, pages 4641-4659.
Read now
Nguyen Hoai An Le, Hoang Van Phan, Jiaqi Yu, Hak-Kim Chan, Adrian Neild & Tuncay Alan. (2018) Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers. International Journal of Nanomedicine 13, pages 1353-1359.
Read now
Yan Ostrovski, Philipp Hofemeier & Josué Sznitman. (2016) Augmenting regional and targeted delivery in the pulmonary acinus using magnetic particles. International Journal of Nanomedicine 11, pages 3385-3395.
Read now
Gabriela Garrastazu Pereira, Amanda Jane Lawson, Francesca Buttini & Fabio Sonvico. (2016) Loco-regional administration of nanomedicines for the treatment of lung cancer. Drug Delivery 23:8, pages 2881-2896.
Read now
D. Leoni, B. Encina & J. Rello. (2016) Managing the oncologic patient with suspected pneumonia in the intensive care unit. Expert Review of Anti-infective Therapy 14:10, pages 943-960.
Read now
Wolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Joshua Stopek, Thomas Vogl, Frank Hübner, J Francis Turner, Robert Browning, Konstantinos Zarogoulidis, Antonis Drevelegas, Konstantinos Drevelegas, Kaid Darwiche, Lutz Freitag & Harald Rittger. (2015) DDMC-p53 gene therapy with or without cisplatin and microwave ablation. OncoTargets and Therapy 8, pages 1165-1173.
Read now
Georgia Pitsiou, Paul Zarogoulidis, Dimitris Petridis, Ioannis Kioumis, Sofia Lampaki, John Organtzis, Konstantinos Porpodis, Antonis Papaiwannou, Theodora Tsiouda, Wolfgang Hohenforst-Schmidt, Stylianos Kakolyris, Konstantinos Syrigos, Haidong Huang, Qiang Li, J Francis Turner & Konstantinos Zarogoulidis. (2014) Inhaled tyrosine kinase inhibitors for pulmonary hypertension: a possible future treatment. Drug Design, Development and Therapy 8, pages 1753-1763.
Read now
Paul Zarogoulidis, Ioannis Kioumis, Sofia Lampaki, John Organtzis, Konstantinos Porpodis, Dionysios Spyratos, Georgia Pitsiou, Dimitris Petridis, Athanasia Pataka, Haidong Huang, Qiang Li, Lonny Yarmus, Wolfgang Hohenforst-Schmidt, Nikolaos Pezirkianidis & Konstantinos Zarogoulidis. (2014) Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol. Drug Design, Development and Therapy 8, pages 1065-1072.
Read now
Ivana d'Angelo, Claudia Conte, Agnese Miro, Fabiana Quaglia & Francesca Ungaro. (2014) Core–shell nanocarriers for cancer therapy. Part I: biologically oriented design rules. Expert Opinion on Drug Delivery 11:2, pages 283-297.
Read now
Kaid Darwiche, Paul Zarogoulidis, Leslie Krauss, Filiz Oezkan, Robert Fred Henry Walter, Robert Werner, Dirk Theegarten, Leonidas Sakkas, Antonios Sakkas, Wolfgang Hohenforst-Scmidt, Konstantinos Zarogoulidis & Lutz Freitag. (2013) “One-stop shop” spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology. International Journal of Nanomedicine 8, pages 4533-4542.
Read now
Paul Zarogoulidis, Ioannis Kioumis, Konstantinos Porpodis, Dionysios Spyratos, Kosmas Tsakiridis, Haidong Huang, Qiang Li, J Francis Turner, Robert Browning, Wolfgang Hohenforst-Schmidt & Konstantinos Zarogoulidis. (2013) Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Design, Development and Therapy 7, pages 1115-1134.
Read now
Wolfgang Hohenforst-Schmidt, Paul Zarogoulidis, Kaid Darwiche, Thomas Vogl, Eugene P Goldberg, Haidong Huang, Michael Simoff, Qiang Li, Robert Browning, Francis J Turner, Patrick Le Pivert, Dionysios Spyratos, Konstantinos Zarogoulidis, Seyhan I Celikoglu, Firuz Celikoglu & Johannes Brachmann. (2013) Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies. Drug Design, Development and Therapy 7, pages 571-583.
Read now

Articles from other publishers (120)

C. Jagdale Swati, A. HableAsawaree & R. ChabukswarAnuruddha. 2023. Advances in Novel Formulations for Drug Delivery. Advances in Novel Formulations for Drug Delivery 433 448 .
MANSING PATIL & PINKAL PATEL. (2023) LIPOSOMAL DRY POWDER INHALER: NOVEL PULMONARY TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF LUNG CANCER. International Journal of Applied Pharmaceutics, pages 1-12.
Crossref
Chetna Gupta, Aadya Jaipuria & Nikesh Gupta. (2022) Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments. Pharmaceutics 15:1, pages 139.
Crossref
Virali Arora, Mohammed A.S. Abourehab, Gyan Modi & Prashant Kesharwani. (2022) Dendrimers as prospective nanocarrier for targeted delivery against lung cancer. European Polymer Journal 180, pages 111635.
Crossref
Valérie Forest & Jérémie Pourchez. (2022) Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?. Advanced Drug Delivery Reviews 183, pages 114173.
Crossref
Nabil A. Alhakamy, Solomon Z. Okbazghi, Mohamed A. Alfaleh, Wesam H. Abdulaal, Rana B. Bakhaidar, Mohammed O. Alselami, Majed AL Zahrani, Hani M. Alqarni, Adel F. Alghaith, Sultan Alshehri, Shaimaa M. Badr-Eldin, Hibah M. Aldawsari, Omar D. Al-hejaili, Bander M. Aldhabi & Wael A. Mahdi. (2022) Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells. PLOS ONE 17:2, pages e0264093.
Crossref
Denxybel Montinola, Aimee L. McNamara, Zdenka Kuncic & Hilary L. Byrne. (2022) Investigation of Micron-Scale Radiotherapy Dose Deposition in the Lung: Effect of Magnetic Field and Nanoparticles—a Monte Carlo Simulation. Frontiers in Physics 10.
Crossref
Ayusha Dondulkar, Natasha Akojwar, Chanti Katta, Dharmendra K. Khatri, Neelesh K. Mehra, Shashi B. Singh & Jitender Madan. (2022) Inhalable Polymeric Micro and Nano-immunoadjuvants for Developing Therapeutic Vaccines in the Treatment of Non-small Cell Lung Cancer. Current Pharmaceutical Design 28:5, pages 395-409.
Crossref
Nabil A. Alhakamy, Shaimaa M. Badr-Eldin, Osama A. A. Ahmed, Hibah M. Aldawsari, Solomon Z. Okbazghi, Mohamed A. Alfaleh, Wesam H. Abdulaal, Thikryat Neamatallah, Omar D. Al-hejaili & Usama A. Fahmy. (2022) Green Nanoemulsion Stabilized by In Situ Self-Assembled Natural Oil/Native Cyclodextrin Complexes: An Eco-Friendly Approach for Enhancing Anticancer Activity of Costunolide against Lung Cancer Cells. Pharmaceutics 14:2, pages 227.
Crossref
Hadi Rezaei, Hesameddin Mostaghimi & AliReza Mehdizadeh. (2022) Assessment of combined modality therapy for non-small-cell lung carcinoma: A simulation study concerning concurrent chemo-brachytherapy. Journal of Cancer Research and Therapeutics 18:4, pages 946.
Crossref
Risako Onodera, Shunsuke Morioka, Shinshu Unida, Keiichi Motoyama, Kohei Tahara & Hirofumi Takeuchi. (2022) Design and evaluation of folate-modified liposomes for pulmonary administration in lung cancer therapy. European Journal of Pharmaceutical Sciences 168, pages 106081.
Crossref
Veena Belgamwar, Vidyadevi Bhoyar, Sagar Trivedi & Miral Patel. 2022. Photophysics and Nanophysics in Therapeutics. Photophysics and Nanophysics in Therapeutics 269 290 .
Lakshmi Thangavelu, S. Raghunandhakumar, R. S. Anand, Sri Renukadevi Balusamy, Ezhilarasan Devaraj, Ashok Kumar Veeramuthu, Anitha Roy, Sindhu Ramesh, Haribalan Perumalsamy & Sheba David. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 207 218 .
Keshav Raj Paudel, Saurav Kumar Jha, Venkata Sita Rama Raju Allam, Parteek Prasher, Piyush Kumar Gupta, Rahul Bhattacharjee, Niraj Kumar Jha, Sukriti Vishwas, Sachin K. Singh, Jesus Shrestha, Mohammad Imran, Nisha Panth, Dinesh Kumar Chellappan, Majid Ebrahimi Warkiani, Philip M. Hansbro & Kamal Dua. (2021) Recent Advances in Chronotherapy Targeting Respiratory Diseases. Pharmaceutics 13:12, pages 2008.
Crossref
Paul Zarogoulidis, Christoforos Kosmidis, Nikolaos Kougkas, Aimilios Lallas, Dimitris Petridis, Wolfgang Hohenforst-Schmidt, Haidong Huang, Lutz Freitag & Chrisanthi Sardeli. (2021) Modification of Apremilast from Pills to Aerosol a Future Concept. International Journal of Environmental Research and Public Health 18:21, pages 11590.
Crossref
Seyed Ali Johari, Mehrdad Sarkheil & Shakila Veisi. (2021) Cytotoxicity, oxidative stress, and apoptosis in human embryonic kidney (HEK293) and colon cancer (SW480) cell lines exposed to nanoscale zeolitic imidazolate framework 8 (ZIF-8). Environmental Science and Pollution Research 28:40, pages 56772-56781.
Crossref
N. V. Orlova, O. D. Ostroumova, E. V. Shikh, S. V. Smerdin, E. V. Rebrova & V. А. Dyo. (2021) Lung Injury Induced by Antitumor Drugs: Prevalence, Certain Drugs and Their Mechanisms of Action. Part 2. Tuberculosis and Lung Diseases 99:8, pages 54-60.
Crossref
Vivek Patel, Denish Bardoliwala, Rohan Lalani, Sushilkumar Patil, Saikat Ghosh, Ankit Javia & Ambikanandan Misra. (2021) Development of a dry powder for inhalation of nanoparticles codelivering cisplatin and ABCC3 siRNA in lung cancer . Therapeutic Delivery 12:9, pages 651-670.
Crossref
Xinglong Fan, Tian Wang, Zhongyi Ji, Qingpeng Li, Hongyu Shen & Jun Wang. (2021) Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles. Biomedicine & Pharmacotherapy 141, pages 111830.
Crossref
Arbel Artzy-Schnirman, Sivan Arber Raviv, Ofri Doppelt Flikshtain, Jeny Shklover, Netanel Korin, Adi Gross, Boaz Mizrahi, Avi Schroeder & Josué Sznitman. (2021) Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics. Advanced Drug Delivery Reviews 176, pages 113901.
Crossref
N. V. Orlovа, O. D. Ostroumovа, E. V. Shikh, S. V. Smerdin, E. V. Rebrovа & V. А. Dyo. (2021) Lung Injury Induced by Antitumor Drugs: Diagnosis, Features of the Clinical Course, Risk Factors, Differential Diagnosis, Treatment, and Prevention. Part 1. Tuberculosis and Lung Diseases 99:7, pages 55-62.
Crossref
Ibrahim M. Abdulbaqi, Reem Abou Assi, Anan Yaghmur, Yusrida Darwis, Noratiqah Mohtar, Thaigarajan Parumasivam, Fadi G. Saqallah & Habibah A. Wahab. (2021) Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update. Pharmaceuticals 14:8, pages 725.
Crossref
Denish Bardoliwala, Ankit Javia, Saikat Ghosh, Ambikanandan Misra & Krutika Sawant. (2021) Formulation and clinical perspectives of inhalation-based nanocarrier delivery: a new archetype in lung cancer treatment. Therapeutic Delivery 12:5, pages 397-418.
Crossref
Michael Donkor & Harlan P. Jones. (2021) The Proposition of the Pulmonary Route as an Attractive Drug Delivery Approach of Nano-Based Immune Therapies and Cancer Vaccines to Treat Lung Tumors. Frontiers in Nanotechnology 3.
Crossref
Yan Ostrovski, Semion Dorfman, Wilson Poh, Say Chye Joachim Loo & Josué Sznitman. (2021) Focused targeting of inhaled magnetic aerosols in reconstructed in vitro airway models. Journal of Biomechanics 118, pages 110279.
Crossref
Ashwin J. Mali, Anamika Rokade, Ravindra Kamble, Atmaram Pawar & C. Bothiraja. (2020) Resveratrol-Loaded Microsponge as a Novel Biodegradable Carrier for Dry Powder Inhaler: A New Strategy in Lung Delivery. BioNanoScience 11:1, pages 32-43.
Crossref
Farshad Moradi Kashkooli, M. Soltani, Mohammad Souri, Cameron Meaney & Mohammad Kohandel. (2021) Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine. Nano Today 36, pages 101057.
Crossref
Joydeb Majumder & Tamara Minko. (2020) Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus. Advanced Therapeutics 4:2, pages 2000203.
Crossref
Ian E. Stewart, Ignacio Luz & Ninell P. Mortensen. (2021) Consideration of Metal Organic Frameworks for Respiratory Delivery. KONA Powder and Particle Journal 38:0, pages 136-154.
Crossref
Ridhima Wadhwa, Keshav Raj Paudel, Li Hian Chin, Chian Ming Hon, Thiagarajan Madheswaran, Gaurav Gupta, Jithendra Panneerselvam, Thangavelu Lakshmi, Sachin Kumar Singh, Monica Gulati, Harish Dureja, Alan Hsu, Meenu Mehta, Krishnan Anand, Hari Prasad Devkota, Jestin Chellian, Dinesh Kumar Chellappan, Philip M. Hansbro & Kamal Dua. (2020) Anti‐inflammatory and anticancer activities of Naringenin‐loaded liquid crystalline nanoparticles in vitro. Journal of Food Biochemistry 45:1.
Crossref
S. Roopashree, J. Anitha & S. Rashmi. (2021) Advent of nanomaterial in modern health science and ayurveda. Materials Today: Proceedings 46, pages 9096-9101.
Crossref
Jia Liu, Yan Deng, Daan Fu, Ye Yuan, Qilin Li, Lin Shi, Guobin Wang, Zheng Wang & Lin Wang. (2021) Sericin microparticles enveloped with metal-organic networks as a pulmonary targeting delivery system for intra-tracheally treating metastatic lung cancer. Bioactive Materials 6:1, pages 273-284.
Crossref
Hitesh Malhotra, Anjoo Kamboj & Rupesh K. Gautam. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases 583 608 .
Min Jeong Jo, Yu Jin Lee, Chun-Woong Park, Youn Bok Chung, Jin-Seok Kim, Mi Kyeong Lee & Dae Hwan Shin. (2020) Evaluation of the Physicochemical Properties, Pharmacokinetics, and In Vitro Anticancer Effects of Docetaxel and Osthol Encapsulated in Methoxy Poly(ethylene glycol)-b-Poly(caprolactone) Polymeric Micelles. International Journal of Molecular Sciences 22:1, pages 231.
Crossref
Sulaiman S. Alhudaithi, Rashed M. Almuqbil, Hanming Zhang, Elizabeth R. Bielski, Wei Du, Fatemah S. Sunbul, Paula D. Bos & Sandro R. P. da Rocha. (2020) Local Targeting of Lung-Tumor-Associated Macrophages with Pulmonary Delivery of a CSF-1R Inhibitor for the Treatment of Breast Cancer Lung Metastases. Molecular Pharmaceutics 17:12, pages 4691-4703.
Crossref
Marwa Labib Essa, Maged Abdeltawab El-Kemary, Eman Mohammed Ebrahem Saied, Stefano Leporatti & Nemany Abdelhamid Nemany Hanafy. (2020) Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer. Materials 13:23, pages 5397.
Crossref
Deniz A. Bölükbas, Stefan Datz, Charlotte Meyer‐Schwickerath, Carmela Morrone, Ali Doryab, Dorothee Gößl, Malamati Vreka, Lin Yang, Christian Argyo, Sabine H. Rijt, Michael Lindner, Oliver Eickelberg, Tobias Stoeger, Otmar Schmid, Sandra Lindstedt, Georgios T. Stathopoulos, Thomas Bein, Darcy E. Wagner & Silke Meiners. (2020) Organ‐Restricted Vascular Delivery of Nanoparticles for Lung Cancer Therapy. Advanced Therapeutics 3:7, pages 2000017.
Crossref
Dinesh K. Chellappan, Lim W. Yee, Kong Y. Xuan, Kishen Kunalan, Lim C. Rou, Leong S. Jean, Lee Y. Ying, Lee X. Wie, Jestin Chellian, Meenu Mehta, Saurabh Satija, Sachin K. Singh, Monica Gulati, Harish Dureja, Mateus Webba Da Silva, Murtaza M. Tambuwala, Gaurav Gupta, Keshav R. Paudel, Ridhima Wadhwa, Philip M. Hansbro & Kamal Dua. (2020) Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases. Drug Development Research 81:4, pages 419-436.
Crossref
Mengmeng Zhang, Miao Li, Lina Du, Ji Zeng, Tianbing Yao & Yiguang Jin. (2020) Paclitaxel-in-liposome-in-bacteria for inhalation treatment of primary lung cancer. International Journal of Pharmaceutics 578, pages 119177.
Crossref
Yi Ju, Christina Cortez‐Jugo, Jingqu Chen, Ting‐Yi Wang, Andrew J. Mitchell, Evelyn Tsantikos, Nadja Bertleff‐Zieschang, Yu‐Wei Lin, Jiaying Song, Yizhe Cheng, Srinivas Mettu, Md. Arifur Rahim, Shuaijun Pan, Gyeongwon Yun, Margaret L. Hibbs, Leslie Y. Yeo, Christoph E. Hagemeyer & Frank Caruso. (2020) Engineering of Nebulized Metal–Phenolic Capsules for Controlled Pulmonary Deposition. Advanced Science 7:6, pages 1902650.
Crossref
Subhabrata Ray, Sayani Bhattacharyya, Parthasarathi Panda, Awantika Pandey & Kajal Ghosal. 2020. Nano Medicine and Nano Safety. Nano Medicine and Nano Safety 237 266 .
Nancy Gordon, Kumar Felix & Najat C. Daw. 2020. Current Advances in Osteosarcoma. Current Advances in Osteosarcoma 67 73 .
Caleb F. Anderson, Maria E. Grimmett, Christopher J. Domalewski & Honggang Cui. (2019) Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases. WIREs Nanomedicine and Nanobiotechnology 12:1.
Crossref
Chrysanthi Sardeli, Paul Zarogoulidis, Christoforos Kosmidis, Aikaterini Amaniti, Athanasios Katsaounis, Dimitrios Giannakidis, Charilaos Koulouris, Wolfgang Hohenforst-Schmidt, Haidong Huang, Chong Bai, Nikolaos Michalopoulos, Kosmas Tsakiridis, Konstantinos Romanidis, Panagoula Oikonomou, Konstantina Mponiou, Anastasios Vagionas, Alexandru Marian Goganau, Isaak Kesisoglou & Konstantinos Sapalidis. (2019) Inhaled chemotherapy adverse effects: mechanisms and protection methods. Lung Cancer Management 8:4.
Crossref
Igor Meerovich, D. David Smith & Alekha K. Dash. (2019) Direct solid-phase peptide synthesis on chitosan microparticles for targeting tumor cells. Journal of Drug Delivery Science and Technology 54, pages 101288.
Crossref
James VercoWilliam JohnstonMichael FrostMichael BaltezorPhilip J. Kuehl, Anita Lopez, Andrew Gigliotti, Steven A. Belinsky, Ronald WolffGere diZerega. (2019) Inhaled Submicron Particle Paclitaxel (NanoPac) Induces Tumor Regression and Immune Cell Infiltration in an Orthotopic Athymic Nude Rat Model of Non-Small Cell Lung Cancer. Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:5, pages 266-277.
Crossref
Nazimuddin Chishti, Satveer Jagwani, Dinesh Dhamecha, Sunil Jalalpure & Mohamed Hassan Dehghan. (2019) Preparation, Optimization, and In Vivo Evaluation of Nanoparticle-Based Formulation for Pulmonary Delivery of Anticancer Drug. Medicina 55:6, pages 294.
Crossref
Christoforos Kosmidis, Konstantinos Sapalidis, Paul Zarogoulidis, Chrysanthi Sardeli, Charilaos Koulouris, Dimitrios Giannakidis, Efstathios Pavlidis, Athanasios Katsaounis, Nikolaos Michalopoulos, Stylianos Mantalobas, Georgios Koimtzis, Vyron Alexandrou, Theodora Tsiouda, Aikaterini Amaniti & Issak Kesisoglou. (2019) Inhaled Cisplatin for NSCLC: Facts and Results. International Journal of Molecular Sciences 20:8, pages 2005.
Crossref
James VercoWilliam JohnstonMichael BaltezorPhilip J. Kuehl, Andrew Gigliotti, Steven A. Belinsky, Anita Lopez, Ronald WolffLauren HylleGere diZerega. (2019) Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac ® ) in a Rodent Model . Journal of Aerosol Medicine and Pulmonary Drug Delivery 32:2, pages 99-109.
Crossref
Rémi Rosière, Thierry Berghmans, Paul De Vuyst, Karim Amighi & Nathalie Wauthoz. (2019) The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses. Cancers 11:3, pages 329.
Crossref
Nazrul Islam & Derek Richard. (2019) Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers. Current Cancer Drug Targets 19:3, pages 162-178.
Crossref
Muhammad Raza Shah, Muhammad Imran & Shafi Ullah. 2019. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy. Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy 129 161 .
Rémi Rosière, Karim Amighi & Nathalie Wauthoz. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer 249 268 .
Hadeer M. Abdelaziz, May S. Freag & Ahmed O. Elzoghby. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer 95 121 .
Yan Ostrovski, Simon Dorfman, Maksim Mezhericher, Stavros Kassinos & Josué Sznitman. (2018) Targeted Drug Delivery to Upper Airways Using a Pulsed Aerosol Bolus and Inhaled Volume Tracking Method. Flow, Turbulence and Combustion 102:1, pages 73-87.
Crossref
Kyle C. Roche, Yusra Betul Medik, Zach Rodgers, Sam Warner & Andrew Z. Wang. 2019. Nanotheranostics for Cancer Applications. Nanotheranostics for Cancer Applications 253 274 .
Peter Strong, Kazuhiro Ito, John Murray & Garth Rapeport. (2018) Current approaches to the discovery of novel inhaled medicines. Drug Discovery Today 23:10, pages 1705-1717.
Crossref
Imco Sibum, Paul Hagedoorn, Anne Haaije de Boer, Henderik Willem Frijlink & Floris Grasmeijer. (2018) Challenges for pulmonary delivery of high powder doses. International Journal of Pharmaceutics 548:1, pages 325-336.
Crossref
Wing-Hin Lee, Ching-Yee Loo, Maliheh Ghadiri, Chean-Ring Leong, Paul M. Young & Daniela Traini. (2018) The potential to treat lung cancer via inhalation of repurposed drugs. Advanced Drug Delivery Reviews 133, pages 107-130.
Crossref
Ali DabbaghNoor Hayaty Abu KasimChai Hong YeongTin Wui WongNoorsaadah Abdul Rahman. (2018) Critical Parameters for Particle-Based Pulmonary Delivery of Chemotherapeutics. Journal of Aerosol Medicine and Pulmonary Drug Delivery 31:3, pages 139-154.
Crossref
Senem Çitoğlu, Mustafa Coşkun & Tezer Fırat. (2018) Synthesis and Magneto–Thermal properties of NiPd nanoparticles. Materials Chemistry and Physics 211, pages 489-500.
Crossref
Claudia Conte, Francesca Mastrotto, Vincenzo Taresco, Aleksandra Tchoryk, Fabiana Quaglia, Snjezana Stolnik & Cameron Alexander. (2018) Enhanced uptake in 2D- and 3D- lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra- and intracellular environments. Journal of Controlled Release 277, pages 126-141.
Crossref
R. Rosière, J. Hureaux, V. Levet, K. Amighi & N. Wauthoz. (2018) La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels. Revue des Maladies Respiratoires 35:4, pages 357-377.
Crossref
Qian Zhong. (2017) Co-Spray Dried Mannitol/Poly(amidoamine)-Doxorubicin Dry-Powder Inhaler Formulations for Lung Adenocarcinoma: Morphology, In Vitro Evaluation, and Aerodynamic Performance. AAPS PharmSciTech 19:2, pages 531-540.
Crossref
Hadeer M. Abdelaziz, Mohamed Gaber, Mahmoud M. Abd-Elwakil, Moustafa T. Mabrouk, Mayada M. Elgohary, Nayra M. Kamel, Dalia M. Kabary, May S. Freag, Magda W. Samaha, Sana M. Mortada, Kadria A. Elkhodairy, Jia-You Fang & Ahmed O. Elzoghby. (2018) Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates. Journal of Controlled Release 269, pages 374-392.
Crossref
Kaidi Li, Naixin Liang, Huaxia Yang, Hongsheng Liu & Shanqing Li. (2017) Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo . Oncotarget 8:67, pages 111318-111332.
Crossref
Otmar SchmidCorinne JudYuki UmeharaDominik MuellerAlbert BucholskiFriedrich GruberOliver DenkRoman EgleAlke Petri-FinkBarbara Rothen-Rutishauser. (2017) Biokinetics of Aerosolized Liposomal Ciclosporin A in Human Lung Cells In Vitro Using an Air-Liquid Cell Interface Exposure System . Journal of Aerosol Medicine and Pulmonary Drug Delivery 30:6, pages 411-424.
Crossref
Susanne R. Youngren-OrtizDavid B. HillPeter R. HoffmannKenneth R. MorrisEdward G. BarrettM. Gregory ForestMahavir B. Chougule. (2017) Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer. Journal of Aerosol Medicine and Pulmonary Drug Delivery 30:5, pages 299-321.
Crossref
Sharad Mangal, Wei Gao, Tonglei Li & Qi Zhou. (2017) Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacologica Sinica 38:6, pages 782-797.
Crossref
Sophie Perinel, Jérémie Pourchez, Lara Leclerc, John Avet, Marc Durand, Nathalie Prévôt, Michèle Cottier & Jean M. Vergnon. (2017) Development of an ex vivo human-porcine respiratory model for preclinical studies. Scientific Reports 7:1.
Crossref
Luai Al Rabadi & Raymond Bergan. (2017) A Way Forward for Cancer Chemoprevention: Think Local. Cancer Prevention Research 10:1, pages 14-35.
Crossref
Vincent Levet, Romain Merlos, Rémi Rosière, Karim Amighi & Nathalie Wauthoz. (2017) Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties. International Journal of Pharmaceutics 517:1-2, pages 359-372.
Crossref
Nehal Salahuddin & Ahmed Galal. 2017. Nanostructures for Cancer Therapy. Nanostructures for Cancer Therapy 87 128 .
Stefan Wuttke, Andreas Zimpel, Thomas Bein, Simone Braig, Katharina Stoiber, Angelika Vollmar, Dominik Müller, Kirsten Haastert-Talini, Jörn Schaeske, Meike Stiesch, Gesa Zahn, Alexander Mohmeyer, Peter Behrens, Oliver Eickelberg, Deniz A. Bölükbas & Silke Meiners. (2017) Validating Metal-Organic Framework Nanoparticles for Their Nanosafety in Diverse Biomedical Applications. Advanced Healthcare Materials 6:2, pages 1600818.
Crossref
Rajiv Dhand. 2016. Advances in Pulmonary Drug Delivery. Advances in Pulmonary Drug Delivery 67 92 .
Tian Luo, Cristina Loira-Pastoriza, Harshad P. Patil, Bernard Ucakar, Giulio G. Muccioli, Cynthia Bosquillon & Rita Vanbever. (2016) PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma. Journal of Controlled Release 239, pages 62-71.
Crossref
Moeko Taki, Tatsuaki Tagami, Kaori Fukushige & Tetsuya Ozeki. (2016) Fabrication of nanocomposite particles using a two-solution mixing-type spray nozzle for use in an inhaled curcumin formulation. International Journal of Pharmaceutics 511:1, pages 104-110.
Crossref
Zoi Piperigkou, Konstantina Karamanou, Ayse Basak Engin, Chrysostomi Gialeli, Anca Oana Docea, Demitrios H. Vynios, Mauro S.G. Pavão, Kirill S. Golokhvast, Mikhail I. Shtilman, Athanassios Argiris, Ekaterina Shishatskaya & Aristidis M. Tsatsakis. (2016) Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics. Food and Chemical Toxicology 91, pages 42-57.
Crossref
Rémi Rosière, Matthias Van Woensel, Véronique Mathieu, Ingrid Langer, Thomas Mathivet, Marjorie Vermeersch, Karim Amighi & Nathalie Wauthoz. (2016) Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy. International Journal of Pharmaceutics 501:1-2, pages 148-159.
Crossref
Gemma M. Ryan, Robert J. Bischof, Perenlei Enkhbaatar, Victoria M. McLeod, Linda J. Chan, Seth A. Jones, David J. Owen, Christopher J. H. Porter & Lisa M. Kaminskas. (2015) A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep. Pharmaceutical Research 33:2, pages 510-525.
Crossref
Truffi Marta, Sorrentino Luca, Mazzucchelli Serena, Fiandra Luisa & Corsi Fabio. (2016) What Is the Role of Nanotechnology in Diagnosis and Treatment of Metastatic Breast Cancer? Promising Scenarios for the Near Future. Journal of Nanomaterials 2016, pages 1-16.
Crossref
Alice Pasini, Angelo Delmonte, Anna Tesei, Daniele Calistri & Emanuele Giordano. (2015) Targeting Chromatin-Mediated Transcriptional Control of Gene Expression in Non-Small Cell Lung Cancer Therapy: Preclinical Rationale and Clinical Results. Drugs 75:15, pages 1757-1771.
Crossref
A. Gaisser. (2015) Onkologie und Versorgung in Fach- und Publikumsmedien. Der Onkologe 21:8, pages 734-738.
Crossref
Stepan Koudelka, Pavlina Turanek Knotigova, Josef Masek, Lubomir Prochazka, Robert Lukac, Andrew D. Miller, Jiri Neuzil & Jaroslav Turanek. (2015) Liposomal delivery systems for anti-cancer analogues of vitamin E. Journal of Controlled Release 207, pages 59-69.
Crossref
Sandrine Dufort, Andrea Bianchi, Maxime Henry, François Lux, Géraldine Le Duc, Véronique Josserand, Cédric Louis, Pascal Perriat, Yannick Crémillieux, Olivier Tillement & Jean-Luc Coll. (2015) Nebulized Gadolinium-Based Nanoparticles: A Theranostic Approach for Lung Tumor Imaging and Radiosensitization. Small 11:2, pages 215-221.
Crossref
Jian-Ting Long, Tuck-yun Cheang, Shu-Yu Zhuo, Rui-Fang Zeng, Qiang-Sheng Dai, He-Ping Li & Shi Fang. (2014) Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis. Journal of Nanobiotechnology 12:1.
Crossref
David G. Menter, Sherri L. Patterson, Craig D. Logsdon, Scott Kopetz, Anil K. Sood & Ernest T. Hawk. (2014) Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?. Cancer Prevention Research 7:10, pages 973-992.
Crossref
Seho Park, Young-Jun Kim & Sangyong Jon. (2014) A high-affinity peptide for nicotinic acetylcholine receptor-α1 and its potential use in pulmonary drug delivery. Journal of Controlled Release 192, pages 141-147.
Crossref
Tetsuya Ozeki & Tatsuaki Tagami. (2014) Drug/polymer nanoparticles prepared using unique spray nozzles and recent progress of inhaled formulation. Asian Journal of Pharmaceutical Sciences 9:5, pages 236-243.
Crossref
Tanmoy Sadhukha, Timothy S. Wiedmann & Jayanth Panyam. (2014) Enhancing therapeutic efficacy through designed aggregation of nanoparticles. Biomaterials 35:27, pages 7860-7869.
Crossref
Nathalie Wauthoz & Karim Amighi. (2014) Phospholipids in pulmonary drug delivery. European Journal of Lipid Science and Technology 116:9, pages 1114-1128.
Crossref
Jakob LöndahlWinfried MöllerJoakim H. PagelsWolfgang G. KreylingErik SwietlickiOtmar Schmid. (2014) Measurement Techniques for Respiratory Tract Deposition of Airborne Nanoparticles: A Critical Review. Journal of Aerosol Medicine and Pulmonary Drug Delivery 27:4, pages 229-254.
Crossref
Dong-Hyun Lee, Sung-Su Kim, Shin Seong, Chang-Ryoul Woo & Jae-Bok Han. (2014) A Case of Metastatic Bladder Cancer in Both Lungs Treated with Korean Medicine Therapy Alone. Case Reports in Oncology 7:2, pages 534-540.
Crossref
CD Shaw & KC Carter. (2014) Drug delivery: lessons to be learnt from Leishmania studies . Nanomedicine 9:10, pages 1531-1544.
Crossref
Jessica M. OakesEllen C. BreenMiriam Scadeng, Ghislain S. Tchantchou & Chantal Darquenne. (2014) MRI-based measurements of aerosol deposition in the lung of healthy and elastase-treated rats. Journal of Applied Physiology 116:12, pages 1561-1568.
Crossref
Lisa M. Kaminskas, Victoria M. McLeod, Gemma M. Ryan, Brian D. Kelly, John M. Haynes, Mark Williamson, Neeranat Thienthong, David J. Owen & Christopher J.H. Porter. (2014) Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy. Journal of Controlled Release 183, pages 18-26.
Crossref
Hayley Nehoff, Neha N. Parayath, Sebastien Taurin & Khaled Greish. 2014. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology 65 86 .
Loretta Müller, Andrea D. Lehmann, Blair D. Johnston, Fabian Blank, Peter Wick, Alke Fink & Barbara Rothen-Rutishauser. 2014. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology 205 222 .
Kohei Tahara & Hirofumi Takeuchi. 2014. Mucoadhesive Materials and Drug Delivery Systems. Mucoadhesive Materials and Drug Delivery Systems 297 308 .
Baoquan Zhao, Lan Sun, Wuxu Zhang, Yuxia Wang, Junjing Zhu, Xiaoyu Zhu, Liuzhong Yang, Chunqi Li, Zhenzhong Zhang & Yingge Zhang. (2014) Secretion of intestinal goblet cells: A novel excretion pathway of nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 10:4, pages 839-849.
Crossref
Mitsutaka Murata, Kohei Tahara & Hirofumi Takeuchi. (2014) Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration. European Journal of Pharmaceutics and Biopharmaceutics 86:1, pages 115-119.
Crossref
Fernando Torres Andón & Bengt Fadeel. 2014. Nano-Oncologicals. Nano-Oncologicals 391 424 .
Masahiro Sakagami. (2013) Systemic delivery of biotherapeutics through the lung: opportunities and challenges for improved lung absorption. Therapeutic Delivery 4:12, pages 1511-1525.
Crossref
Paul Zarogoulidis, Dimitris Petridis, Christos Ritzoulis, Qiang Li, Haidong Huang, Yunye Ning, Kaid Darwiche, Lutz Freitag & Konstantinos Zarogoulidis. (2013) Further experimentation of inhaled; Lantus, Actrapid and Humulin with todays’ production systems. International Journal of Pharmaceutics 458:1, pages 39-47.
Crossref
Raphaelle Fanciullino, Joseph Ciccolini & Gérard Milano. (2013) Challenges, expectations and limits for nanoparticles-based therapeutics in cancer: A focus on nano-albumin-bound drugs. Critical Reviews in Oncology/Hematology 88:3, pages 504-513.
Crossref
G M Sacha & P Varona. (2013) Artificial intelligence in nanotechnology. Nanotechnology 24:45, pages 452002.
Crossref
Paul Zarogoulidis, Dimitris Petridis, Christos Ritzoulis, Kaid Darwiche, Ioannis Kioumis, Konstantinos Porpodis, Dionysios Spyratos, Wolfgang Hohenforst-Schmidt, Lonny Yarmus, Haidong Huang, Qiang Li, Lutz Freitag & Konstantinos Zarogoulidis. (2013) Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics. International Journal of Pharmaceutics 456:2, pages 325-331.
Crossref
Paul Zarogoulidis, Ioannis Kioumis, Christos Ritzoulis, Dimitris Petridis, Kaid Darwiche, Konstantinos Porpodis, Dionysis Spyratos, Scott Parrish, Robert Browning, Qiang Li, J. Francis Turner, Lutz Freitag & Konstantinos Zarogoulidis. (2013) New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam. International Journal of Pharmaceutics 455:1-2, pages 182-188.
Crossref
Paul ZarogoulidisKaid Darwiche, Leslie Krauss, Haidong Huang, George A Zachariadis, Anna Katsavou, Wolfgang Hohenforst-Schmidt, Antonis Papaiwannou, Thomas J Vogl, Lutz Freitag, George Stamatis & Konstantinos Zarogoulidis. (2013) Inhaled cisplatin deposition and distribution in lymph nodes in stage II lung cancer patients. Future Oncology 9:9, pages 1307-1313.
Crossref
Paul Zarogoulidis, Dimitris Petridis, Christos Ritzoulis, Kaid Darwiche, Dionysis Spyratos, Haidong Huang, Eugene P. Goldberg, Lonny Yarmus, Qiang Li, Lutz Freitag & Konstantinos Zarogoulidis. (2013) Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: Back to drawing the residual cup. International Journal of Pharmaceutics 453:2, pages 480-487.
Crossref
Paul ZarogoulidisKaid Darwiche, Wolfgang Hohenforst-Schmidt, Haidong Huang, Qiang Li, Lutz Freitag & Konstantinos Zarogoulidis. (2013) Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer. Future Oncology 9:8, pages 1171-1194.
Crossref
M. Howell, C. Wang, A. Mahmoud, G. Hellermann, S. S. Mohapatra & S. Mohapatra. (2013) Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases. Drug Delivery and Translational Research 3:4, pages 352-363.
Crossref
Christian A Ruge, Julian Kirch & Claus-Michael Lehr. (2013) Pulmonary drug delivery: from generating aerosols to overcoming biological barriers—therapeutic possibilities and technological challenges. The Lancet Respiratory Medicine 1:5, pages 402-413.
Crossref
Jessica M. Oakes, Miriam Scadeng, Ellen C. Breen, G. Kim Prisk & Chantal Darquenne. (2013) Regional Distribution of Aerosol Deposition in Rat Lungs Using Magnetic Resonance Imaging. Annals of Biomedical Engineering 41:5, pages 967-978.
Crossref
Kaid Darwiche, Paul ZarogoulidisNikos K Karamanos, Kalliopi Domvri, Ekaterini Chatzaki, Theodoros C Constantinidis, Stylianos Kakolyris & Konstantinos Zarogoulidis. (2013) Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology. Future Oncology 9:4, pages 505-525.
Crossref
Jyothi U. Menon, Aniket S. Wadajkar, Zhiwei Xie & Kytai T. Nguyen. 2013. Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering. Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering 167 202 .
Paul ZarogoulidisGeorgia Trakada & Konstantinos Zarogoulidis. (2013) A chrono-target chemotherapy treatment model for lung cancer treatment. Therapeutic Delivery 4:1, pages 5-8.
Crossref
Manisha Singh, Dania Movia, Omar K. Mahfoud, Yuri Volkov & Adriele Prina-Mello. (2013) Silver nanowires as prospective carriers for drug delivery in cancer treatment: an in vitro biocompatibility study on lung adenocarcinoma cells and fibroblasts. European Journal of Nanomedicine 5:4.
Crossref
Paul ZarogoulidisChrisostomi Gialeli & Nikos K Karamanos. (2012) Inhaled chemotherapy in lung cancer: safety concerns of nanocomplexes delivered. Therapeutic Delivery 3:9, pages 1021-1023.
Crossref
Paul Zarogouldis, Nikos K. Karamanos, Konstantinos Porpodis, Kalliopi Domvri, Haidong Huang, Wolfgang Hohenforst-Schimdt, Eugene P. Goldberg & Konstantinos Zarogoulidis. (2012) Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology. International Journal of Molecular Sciences 13:9, pages 10828-10862.
Crossref